Alkem Laboratories Ltd. Financial Overview
Alkem Laboratories Ltd.'s market cap is currently ₹668.84B. The company's EPS TTM is ₹63.99; its P/E ratio is 28.33; and it has a dividend yield of 0.80%. Alkem Laboratories Ltd. is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is ₹57.50. See an overview of income statement, balance sheet, and cash flow financials.
